Bioeconomy and modern biotechnology are inextricably linked …

… and the economic use of biotechnological innovations must be justified. The interdisciplinary approach ensures the integration of social, legal and scientific aspects of biotechnology. Only in the case of the synergic effects of these three areas the optimal development of innovative bio-economy will be possible. By identifying the most important factors limiting the implementation of innovative biotechnology, it will be possible to adapt the global strategy.

An important aspect is not only to collect and summarize existing knowledge, but to develop new solutions, and suggest  directions of changes and developments, taking into account local specificities of the EU member states. We have to remember that EU states are not self-sufficient in food/feed. The agriculture products  do have strategic  value.

One of the priorities is to provide data on commercial potential of new products, especially taking into account well recognized societal challenge identified in EU, that is “food and feed security and safety, the competitiveness of the European agri-food industry and the sustainability of food production, processing and consumption.

In Europe, there is a growing lack of domestic proteins for the nutrition of animals. The majority of European protein needs are covered by the import of soy products. This means that there is a growing environmental and ethical concern, since this increasing need for soybean is at the expense of ecologically important rainforests and force European society to accept the import of genetically modified plants. Therefore, alternatives are urgently needed. These are on the one hand indigenously grown legumes, on the other hand co-products from other industrial processes. The real solutions will be  find  in bioeconomy.

We will talk about it during ECB2016.


The European Congress on Biotechnology is the leading conference for academic and industrial biotechnologists in Europe, organised by the European Federation of Biotechnology. As a sequel to the highly acclaimed 16th European Congress on Biotechnology in Edinburgh, July 2014, the Scientific Programme in the Krakow Congress will include:

  • Plenary lectures by stellar speakers who are leading biotechnological developments
  • 25 symposia that span all colours of biotechnology
  • A fully-integrated Eurobiotech programme highlighting top Central European biotechnology
  • Invited speakers who are world leaders in their fields
  • Satellite events on the opening day of the Congress, Sunday 3 July 2016
  • 200 short talks selected from submitted abstracts for symposia or satellite events
  • Trade exhibition
  • Poster sessions located close to the Trade exhibition
  • Opportunities to hear about developments in the Asian Federation of Biotechnology
  • Highlight events that focus on current challenges and controversies
  • A Publications Workshop to help young biotechnologists publish their work in leading journals
  • An “Open Space” event to bring innovative ideas to the attention of industry
  • Meeting point with refreshments throughout the day

All of the above will be hosted in the state–of–the–art EXPO Krakow Congress Centre.